Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
Crossref DOI link: https://doi.org/10.1038/s41598-023-41836-5
Published Online: 2023-09-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Su, Qingchang
Wang, Xin
Zhu, Rongchen
Liu, Cuicui
Sun, Shanping
Text and Data Mining valid from 2023-09-08
Version of Record valid from 2023-09-08
Article History
Received: 16 April 2023
Accepted: 31 August 2023
First Online: 8 September 2023
Competing interests
: The authors declare no competing interests.